ImageneBio, Inc.
IMANasdaqCIK 1835579HealthcareFiscal year ends Dec 31
Reports and events: 96 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0508:10 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-333920 |
| 2026-08-0508:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-333912 |
| 2026-07-2316:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-314167 |
| 2026-06-2616:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-285424 |
| 2026-06-1716:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-274139 |
| 2026-05-0716:24 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-212073 |
| 2026-05-0716:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-211935 |
| 2026-04-3016:31 ET | DEF 14A | Proxy statementPeriod 2026-06-16 | 0001140361-26-018267 |
| 2026-04-2919:07 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-26-000483 |
| 2026-04-2116:00 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-26-166691 |
| 2026-04-1307:10 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-151942 |
| 2026-03-1716:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-110945 |
| 2026-03-1008:33 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-099434 |
| 2026-03-1008:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-099422 |
| 2026-02-1716:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-054684 |
| 2025-12-1816:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-324798 |
| 2025-11-1907:50 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-286984 |
| 2025-11-1207:30 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-275932 |
| 2025-11-1207:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-275910 |
| 2025-11-0516:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-266889 |
| 2025-10-2908:00 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement | 0001193125-25-254697 |
| 2025-10-2209:03 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-245823 |
| 2025-10-1016:45 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-237161 |
| 2025-09-0816:18 ET | S-1 | Registration statement | 0001193125-25-198360 |
| 2025-08-1217:19 ET | 8-K/A | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001193125-25-179093 |
| 2025-08-0517:15 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-25-173626 |
| 2025-08-0116:59 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-171747 |
| 2025-07-3021:28 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-25-000711 |
| 2025-07-2916:53 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-020462 |
| 2025-07-2906:04 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-167089 |
| 2025-07-2814:16 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001373604-25-000095 |
| 2025-07-2512:23 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-165170 |
| 2025-07-2417:17 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-098414 |
| 2025-07-2409:18 ET | 8-K | 8.01 Other events | 0001193125-25-163990 |
| 2025-07-2216:20 ET | 8-K | 8.01 Other events | 0001193125-25-162584 |
| 2025-07-1616:40 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-159910 |
| 2025-07-1516:50 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-159400 |
| 2025-07-1108:34 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-157867 |
| 2025-07-0116:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-154016 |
| 2025-06-1820:23 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-25-000619 |
| 2025-06-1612:21 ET | SCHEDULE 13D | Ownership report, active investor | 0001373604-25-000088 |
| 2025-05-0808:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066411 |
| 2025-03-0608:10 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-034188 |
| 2024-12-2308:37 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-283722 |
| 2024-11-0708:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122818 |
| 2024-08-0816:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-093880 |
| 2024-07-1216:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-178568 |
| 2024-06-1016:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-158321 |
| 2024-05-2816:24 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-148112 |
| 2024-05-1316:33 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-058715 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.